Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Biosafety and Health|May 1, 2023
Immunological considerations for laboratory staff and COVID-19 biosafetyAmbroise Kouame Kintossou, Stephanie Villar, Zisis Kozlakidis
Biosafety and Health|June 28, 2021
Biosafety and biobanking: Current understanding and knowledge gapsJulie Roux, Maissa Zeghidi, Stephanie Villar, et al.
Hepatitis Research and Treatment|August 27, 2011
TP53 Mutations and HBX Status Analysis in Hepatocellular Carcinomas from Iran: Evidence for Lack of Association between HBV Genotype D and TP53 R249S MutationsBehnoush Abedi-Ardekani, Doriane Gouas, Stephanie Villar, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 21, 2005
Quantitative analysis of plasma TP53 249Ser-mutated DNA by electrospray ionization mass spectrometryMatilde E Lleonart, Gregory D Kirk, Stephanie Villar, et al.
Plos One|January 5, 2012
Extremely high Tp53 mutation load in esophageal squamous cell carcinoma in Golestan Province, IranBehnoush Abedi-Ardekani, Farin Kamangar, Masoud Sotoudeh, et al.
International Journal of Cancer|September 27, 2021
Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposureSandra Karanović, Maude Ardin, Zuojian Tang, et al.
Genome Research|July 26, 2017
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumorsMi Ni Huang, Willie Yu, Wei Wei Teoh, et al.
Pageof 2